Asosiy kontentga oʻtish
Maqola

Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Zhiyuan ChenKey Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, ChinaAndrew S. AzmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAXinhua ChenDepartment of Infectious Diseases, Huashan Hospital, School of Public Health, Fudan University, Shanghai, ChinaJunyi ZouKey Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, ChinaYuyang TianKey Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, ChinaRuijia SunDepartment of Infectious Diseases, Huashan Hospital, School of Public Health, Fudan University, Shanghai, ChinaXiangyanyu XuKey Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, ChinaYani WuSchool of Public Health, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaWanying LuDepartment of Infectious Diseases, Huashan Hospital, School of Public Health, Fudan University, Shanghai, ChinaShijia GeDepartment of Infectious Diseases, Huashan Hospital, School of Public Health, Fudan University, Shanghai, ChinaZeyao ZhaoKey Laboratory of Public Health Safety, Fudan University, Ministry of Education, Shanghai, ChinaJuan YangDepartment of Infectious Diseases, Huashan Hospital, School of Public Health, Fudan University, Shanghai, ChinaDaniel T. LeungDivision of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USADaryl DommanCenter for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USAHongjie YuNational Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China. [email protected]
2022en
ABI

Annotatsiya

Genomic surveillance has shaped our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. We performed a global landscape analysis on SARS-CoV-2 genomic surveillance and genomic data using a collection of country-specific data. Here, we characterize increasing circulation of the Alpha variant in early 2021, subsequently replaced by the Delta variant around May 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 45 countries performing a high level of routine genomic surveillance and 96 countries with a high availability of SARS-CoV-2 sequencing. We also observed a marked heterogeneity of sequencing percentage, sequencing technologies, turnaround time and completeness of released metadata across regions and income groups. A total of 37% of countries with explicit reporting on variants shared less than half of their sequences of variants of concern (VOCs) in public repositories. Our findings indicate an urgent need to increase timely and full sharing of sequences, the standardization of metadata files and support for countries with limited sequencing and bioinformatics capacity.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba